Skip to content

AB2: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AB2

BE 0436.055.580
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€5,656
2024 · €8,800-€14,455
Equity
€154,122
2024 · €159,778-€5,656
Cash
€460
2024 · €154+€307
Balance sheet total
€278,131
2024 · €280,910-€2,779

Largest movements

2024 to 2025
Assets
  • Receivables after one year -€22,600

    down €22,600 (-8.1%), from €278,236 to €255,636

  • Receivables within one year +€19,586

    up €19,586 (+1194.5%), from €1,640 to €21,226

    of which Other amounts receivable: +€20,697

Equity and liabilities
  • Other debts +€5,862

    up €5,862 (+37.9%), from €15,473 to €21,335

  • Profit (loss) carried forward -€5,656

    down €5,656 (-4.3%), from €132,488 to €126,832

Income statement
  • Gross operating margin -€16,320

    down €16,320, from €11,632 to -€4,688

  • Financial charges -€1,103

    down €1,103 (-65.5%), from €1,683 to €580

  • Financial income +€658

    up €658, from €0 to €658

  • Depreciation +€193

    up €193 (+128.7%), from €150 to €344

  • Taxes -€162

    down €162 (-98.7%), from €164 to €2

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €8,800
Gross operating margin -€16,320
Depreciation -€193
Other operating charges +€33
Other operating items +€101
Financial income +€658
Financial charges +€1,103
Taxes +€162
Result 2025 -€5,656

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€3,650
Investment -€240
Financing -€3,103
Cash 2024 €154
Net result for the year -€5,656
Depreciation +€344
Receivables after one year +€22,600
Receivables within one year -€19,586
Deferred charges and accrued income -€32
Trade debts +€282
Tax, wage and social debts -€164
Other debts +€5,862
Investment in fixed assets (net) -€240
Debts after one year -€2,354
Short-term financial debts -€749
Cash 2025 €460
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €280,910 €278,131 -€2,779 -1.0%
Fixed assets 21/28 €881 €777 -€104 -11.8%
Tangible fixed assets 22/27 €881 €537 -€344 -39.0%
Furniture and vehicles 24 €881 €537 -€344 -39.0%
Financial fixed assets 28 €0 €240 +€240
Current assets 29/58 €280,030 €277,354 -€2,675 -1.0%
Amounts receivable after more than one year 29 €278,236 €255,636 -€22,600 -8.1%
Other amounts receivable 291 €278,236 €255,636 -€22,600 -8.1%
Amounts receivable within one year 40/41 €1,640 €21,226 +€19,586 +1194.5%
Trade receivables 40 €1,111 €0 -€1,111 -100.0%
Other amounts receivable 41 €529 €21,226 +€20,697 +3915.9%
Cash at bank and in hand 54/58 €154 €460 +€307 +199.3%
Deferred charges and accrued income 490/1 €0 €32 +€32
Total equity and liabilities 10/49 €280,910 €278,131 -€2,779 -1.0%
Equity 10/15 €159,778 €154,122 -€5,656 -3.5%
Contributions 10/11 €24,789 €24,789 = 0.0%
Reserves 13 €2,500 €2,500 = 0.0%
Non-distributable reserves 130/1 €2,500 €0 -€2,500 -100.0%
Reserves not available under the articles 1311 €2,500 €0 -€2,500 -100.0%
Distributable reserves 133 - €2,500 +€2,500
Profit (loss) carried forward 14 €132,488 €126,832 -€5,656 -4.3%
Amounts payable 17/49 €121,133 €124,010 +€2,877 +2.4%
Amounts payable after more than one year 17 €2,354 €0 -€2,354 -100.0%
Financial debts 170/4 €2,354 €0 -€2,354 -100.0%
Amounts payable within one year 42/48 €16,518 €21,749 +€5,231 +31.7%
Financial debts 43 €749 €0 -€749 -100.0%
Credit institutions 430/8 €749 €0 -€749 -100.0%
Trade debts 44 €132 €414 +€282 +213.5%
Suppliers 440/4 €132 €414 +€282 +213.5%
Taxes, remuneration and social security 45 €164 €0 -€164 -100.0%
Taxes 450/3 €164 €0 -€164 -100.0%
Other amounts payable 47/48 €15,473 €21,335 +€5,862 +37.9%
Accrued charges and deferred income 492/3 €102,260 €102,260 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €150 €344 +€193 +128.7%
Other operating charges 640/8 €734 €701 -€33 -4.6%
Non-recurring operating charges 66A €101 €0 -€101 -100.0%
Gross operating margin 9900 €11,632 -€4,688 -€16,320
Operating profit (loss) 9901 €10,646 -€5,732 -€16,379
Financial income 75/76B €0 €658 +€658
Recurring financial income 75 €0 €658 +€658
Financial charges 65/66B €1,683 €580 -€1,103 -65.5%
Recurring financial charges 65 €1,683 €580 -€1,103 -65.5%
Profit (loss) for the period before taxes 9903 €8,964 -€5,654 -€14,618
Income taxes 67/77 €164 €2 -€162 -98.7%
Profit (loss) for the period 9904 €8,800 -€5,656 -€14,455
Profit (loss) for the period to be appropriated 9905 €8,800 -€5,656 -€14,455

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.